Amanta Healthcar

{
  "main_header": {
    "sid": 10039743,
    "name": "Amanta Healthcar",
    "stock_name": "Amanta Healthcar",
    "full_name": "Amanta Healthcare Ltd",
    "name_url": "stocks-analysis/amanta-healthcar",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "103.75",
    "chg": -0.89,
    "chgp": "-0.85%",
    "dir": -1,
    "prev_price": "104.64",
    "mcapval": "402.85 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544502,
    "symbol": "AMANTA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE084K01015",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "22.74 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amanta-healthcar-10039743-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Amanta Healthcar is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-3789744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AmantaHealthcar_mojoScore_3789744.png",
        "date": "2026-01-12 10:10:21",
        "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Amanta Healthcar is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-by-marketsmojo-3773041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AmantaHealthcar_mojoScore_3773041.png",
        "date": "2025-12-29 10:10:52",
        "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Amanta Healthcare Evaluation Sees Shift Amidst Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-downgraded-to-strong-sell-amid-weak-fundamentals-and-elevated-debt-3762065",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AmantaHealthcar_mojoScore_3762065.png",
        "date": "2025-12-18 08:25:40",
        "description": "Amanta Healthcare’s recent market assessment reflects a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s long-term sales trajectory, debt servicing capacity, and return ratios have influenced a revision in its evaluation, highlighting both challenges and areas of relative strength within a competitive sector."
      },
      {
        "title": "Amanta Healthcare’s Business Fundamentals Undergo Notable Evaluation Adjustments",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-downgraded-to-below-average-quality-amidst-weak-financial-metrics-3761849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AmantaHealthcar_qualitydot_3761849.png",
        "date": "2025-12-18 08:00:11",
        "description": "Amanta Healthcare, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its business fundamentals as reflected in recent evaluation adjustments. Key financial metrics such as return on equity, return on capital employed, debt levels, and growth indicators reveal a nuanced picture of the company’s operational and financial health amid a challenging market environment."
      }
    ],
    "total": 4,
    "sid": "10039743",
    "stock_news_url": "https://www.marketsmojo.com/news/amanta-healthcare-10039743"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Amanta Healthcar is Rated Sell

2026-01-12 10:10:21

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell by MarketsMOJO

2025-12-29 10:10:52

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Amanta Healthcare Evaluation Sees Shift Amidst Mixed Financial Signals

2025-12-18 08:25:40

Amanta Healthcare’s recent market assessment reflects a nuanced picture shaped by its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s long-term sales trajectory, debt servicing capacity, and return ratios have influenced a revision in its evaluation, highlighting both challenges and areas of relative strength within a competitive sector.

Read full news article

Amanta Healthcare’s Business Fundamentals Undergo Notable Evaluation Adjustments

2025-12-18 08:00:11

Amanta Healthcare, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in its business fundamentals as reflected in recent evaluation adjustments. Key financial metrics such as return on equity, return on capital employed, debt levels, and growth indicators reveal a nuanced picture of the company’s operational and financial health amid a challenging market environment.

Read full news article

View All News